Biocon, Cipla, Dr Reddy’s, Other Pharma Stocks In Red Amid Trump Tariff Uncertainty; What Should Investors Do?

The funds will be used to purchase outstanding optionally convertible debentures issued by the company’s subsidiary Biocon ...

The decision comes after receiving approvals from the Board of Directors in April and from shareholders through a postal ...

Shares of Biocon Ltd., surged 1.3% on Tuesday after the company's board of directors approved the floor price for the share ...

Bengaluru-based Biocon Ltd. closes the window to list its arm, Biocon Biologics Ltd., as it raises Rs 4,500 crore to provide ...

Biocon shares will be in focus of stock market investors on Tuesday, 17 June 2025, after the company's board of directors ...

Biocon launches Rs 4,500-crore QIP to raise funds for debt repayment, Biocon Biologics investment, and corporate needs ...

The company has set the floor price for the issue at Rs 340.20 per equity share, in line with the pricing formula prescribed ...

Kiran Mazumdar-Shaw led global bio-pharmaceutical firm Biocon Ltd plans to launch its proposed QIP (qualified institutional ...

Biocon has launched a ₹4,500 crore Qualified Institutional Placement, setting the floor price at ₹340.20 per share. Proceeds ...

The GIFT Nifty was trading 0.02% or 6 points down at 25,004 as of 6:40 a.m., which implied a slight lower open for the ...

Biocon, operating in the Pharmaceuticals sector and classified as a Midcap on the BSE, currently has its share price at ₹355.45. The stock has experienced fluctuations today, with a low of ...